MLAB 1211 Urinalysis/Body Fluids
 

Unit 4 Objectives: Body Fluids Other Than Urine

  1. Assess the laboratory’s roll in the testing of body fluids.
  2. Outline the flow of cerebrospinal fluid (CSF) through brain and spinal column, indicating sources of production and reabsorption.
  3. Discuss the blood-brain barrier to include its function and effects on the CSF.
  4. Explain the three (3) major functions of cerebrospinal fluid.
  5. List four major categories of disease affecting brain andspinal cord.
  6. Identify three (3) reasons for CSF analysis.
  7. Outline the procedures used in obtaining CSF including how it is appropriately distributed throughout the laboratory sections.
  8. Discuss the appearance of CSF specimens including terms used to describe normal and abnormal specimens and their significance.
  9. Differentiate the laboratory findings of a bloody specimen caused by a cerebral hemorrhage and one that resulted from a traumatic tap.
  10. Analyze the types of inclusions seen in macrophages following intracranial hemorrhage.
  11. Calculate CSF white and red blood cell counts when given the number of cells seen, specimen dilution, and the number of squares counted.
  12. Associate bacterial, viral, and parasitic meningitis, as well as allergic reactions, leukemia, and carcinoma with the types of cells primarily seen.
  13. Describe the appearance of ependymal, macrophage, and malignant cells.
  14. Evaluate CSF chemistry tests: protein, glucose, lactate, and glutamine to determine whether they are normal or abnormal and the significance of the abnormal results.
  15. List three (3) pathologic conditions that produce an elevated CSF protein.
  16. Explain the basic principles associated with the turbidimetric and the dye-binding methods of CSF protein analysis.
  17. Name two (2) pathologic conditions resulting in a decreased CSF glucose.
  18. Briefly describe the MS Panel performed on CSF and its significance.
  19. List the most common cause of meningitis in neonates, children, adults, and the immunocompromised patient.
  20. For each of the following CSF tests and observations identify the organism most often associated with a positive result: India ink preparation, acid fast stain, VDRL and pellicle formation.
  21. Discuss serous fluids including: the respective body cavities associated from which they come, their function in those body cavities, the name of the procedure to obtain and the reasons for analyzing the fluid.
  22. Define thoracentesis, paracentesis, pericardocentesis, and effusion.
  23. Differentiate between transudates and exudates including two (2) conditions that would cause the formation of each.
  24. Given the number of cells seen, dilution factor and number of squares counted calculate serous fluid cell counts.
  25. Describe the appearance and significance of cells seen on serous fluid differentials including mesothelials, malignant and LE cells.
  26. Briefly describe the most common chemistry tests performed on serous and synovial fluids.
  27. Identify the importance of cytologic exam for serous fluids.
  28. Assess the composition of normal synovial fluid and explain the significance of hyaluronic acid.
  29. List two (2) functions of synovial fluid.
  30. State three (3) reasons for synovial fluid analyses.
  31. Define arthrocentesis.
  32. Briefly compare and contrast the two (2) tests for synovial fluid viscosity.
  33. Given the number of cells seen, dilution factor, and number of squares counted calculate a synovial fluid cell count.
  34. State the types of diluting fluids that may and may not be used for synovial fluid cell counts.
  35. Name the type of white blood cell (WBC) predominantly seen in bacterial infections of synovial cavities.
  36. Describe the appearance of synovial lining cells and LE cells and state their significance.
  37. Identify crystals seen in synovial fluid, and state their significance in the diagnosis of gout.
  38. When evaluating an infection of the synovial cavity correlate the most common cause of the infection with the appropriate susceptible population: children, adults, and elderly patients.
Last Update: August 7, 2009
Web Author: Terry Kotrla, MS, MT(ASCP)BB
Comments: kotrla@austincc.edu
Copyright ©2000 by Terry Kotrla - All Rights Reserved